140 related articles for article (PubMed ID: 16123803)
1. TGF-beta signaling in T cells: roles in lymphoid and epithelial neoplasia.
Letterio JJ
Oncogene; 2005 Aug; 24(37):5701-12. PubMed ID: 16123803
[TBL] [Abstract][Full Text] [Related]
2. Loss of Smad3 in acute T-cell lymphoblastic leukemia.
Wolfraim LA; Fernandez TM; Mamura M; Fuller WL; Kumar R; Cole DE; Byfield S; Felici A; Flanders KC; Walz TM; Roberts AB; Aplan PD; Balis FM; Letterio JJ
N Engl J Med; 2004 Aug; 351(6):552-9. PubMed ID: 15295048
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
Seo T; Park J; Choe J
Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta signaling regulates CD8+ T cell responses to high- and low-affinity TCR interactions.
Mehal WZ; Sheikh SZ; Gorelik L; Flavell RA
Int Immunol; 2005 May; 17(5):531-8. PubMed ID: 15824070
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
Zhang L; Yi H; Xia XP; Zhao Y
Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
Javelaud D; Mauviel A
Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
[TBL] [Abstract][Full Text] [Related]
9. Effect of TGF-beta/Smad signaling pathway on lung myofibroblast differentiation.
Gu L; Zhu YJ; Yang X; Guo ZJ; Xu WB; Tian XL
Acta Pharmacol Sin; 2007 Mar; 28(3):382-91. PubMed ID: 17303001
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease.
Benahmed M; Meresse B; Arnulf B; Barbe U; Mention JJ; Verkarre V; Allez M; Cellier C; Hermine O; Cerf-Bensussan N
Gastroenterology; 2007 Mar; 132(3):994-1008. PubMed ID: 17324400
[TBL] [Abstract][Full Text] [Related]
11. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells.
Zheng S; Chen A
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G113-23. PubMed ID: 16959952
[TBL] [Abstract][Full Text] [Related]
12. [Transforming growth factor-betas: smad signaling and roles in physiopathology].
Javelaud D; Mauviel A
Pathol Biol (Paris); 2004 Feb; 52(1):50-4. PubMed ID: 14761714
[TBL] [Abstract][Full Text] [Related]
13. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
[TBL] [Abstract][Full Text] [Related]
14. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling.
Sun Y; Lowther W; Kato K; Bianco C; Kenney N; Strizzi L; Raafat D; Hirota M; Khan NI; Bargo S; Jones B; Salomon D; Callahan R
Oncogene; 2005 Aug; 24(34):5365-74. PubMed ID: 16007227
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway.
Pavio N; Battaglia S; Boucreux D; Arnulf B; Sobesky R; Hermine O; Brechot C
Oncogene; 2005 Sep; 24(40):6119-32. PubMed ID: 16007207
[TBL] [Abstract][Full Text] [Related]
16. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
Brown KA; Pietenpol JA; Moses HL
J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
18. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
Yu Z; Xing Y
Biochem Biophys Res Commun; 2006 Feb; 340(3):929-34. PubMed ID: 16410076
[TBL] [Abstract][Full Text] [Related]
20. Human epithelial ovarian carcinoma cell-derived cytokines cooperatively induce activated CD4+CD25-CD45RA+ naïve T cells to express forkhead box protein 3 and exhibit suppressive ability in vitro.
Zhao X; Ye F; Chen L; Lu W; Xie X
Cancer Sci; 2009 Nov; 100(11):2143-51. PubMed ID: 19673890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
